Across all six studies, the safety findings were consistent: no serious adverse events, no immunogenic responses, no changes in IGF-1, no glucose or insulin disruption
Glutathione hasn't been studied adequately for safety in pregnancy and breastfeeding, so it's best avoided during these life phases
T h 2, T h 17, T h 22, and T fh cells) remain controversial, there is a propensity of evidence to support a clear proatherogenic role for T h 1 cells and an atheroprotective role for Tregs
Epigenetics, a key for unlocking complex cns disorders
Until it reports and a regulator reviews it, there is no approval and no confirmed long-term safety verdict that is the central evidence gap
Formulation The TRH was lyophilized with no additives